Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Patients: A Multicenter, Open Label Phase 1/2 Study.

Details

Language :

English

ISSN :

21522650

Volume :

17

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

122646644

Full Text :

https://doi.org/10.1016/j.clml.2017.03.108